2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Mental Disorder: new trials by email Literature Review of Mental Disorder trials Research Report on Mental Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry? liraglutide 3 mg (Saxenda®) once-daily - Mental Disorder, Metabolic Disturbance | Phase 4 | Completed | Anders Fink-Jensen, MD, DMSci | 24 | 2021-07-01 | 2023-08-08 |
| Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections Amoxicillin - Autoimmune Disease, Mental Disorder | Phase 4 | Completed | National Institute of Mental Health (NIMH) | 30 | 1997-07-01 | 2008-03-04 |
Mental Disorders (2) · Autoimmune Diseases (1) · Obesity (1) · Obsessive-Compulsive Disorder (1) · Overweight (1) · Streptococcal Infections (1) · Tic Disorders (1)
Anxiety Disorders (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Body Weight (1) · Central Nervous System Diseases (1) · Gram-Positive Bacterial Infections (1) · Immune System Diseases (1) · Infections (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodevelopmental Disorders (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1)
Amoxicillin (1) · Liraglutide (1)
Anders Fink-Jensen, MD, DMSci (1) · National Institute of Mental Health (NIMH) (1)
Denmark (1) · United States (1)